WELGENE
威健股份有限公司
WELGENE focuses on sequencing, proteomics, gene arrays, clinical testing and instrument / reagent distribution, as of 2026-11-01.
Pipeline and products
No publicly disclosed new-drug pipeline.
Key events
Related Drugnews articles
No related articles in this language.